Amoy Diagnostics is at the forefront of precision oncology, utilizing advanced technologies to enhance cancer diagnosis and treatment. Their proprietary **ddCapture® Technology** employs biotinylated oligonucleotide baits to efficiently hybridize to target regions of interest, making it suitable for both formalin-fixed paraffin-embedded (FFPE) tissues and liquid biopsies. This method ensures high sensitivity in variant detection by tagging each DNA molecule with a unique molecular index, thereby eliminating amplification and sequencing biases. Additionally, the **HANDLE® Technology** simplifies next-generation sequencing (NGS) library preparation, allowing for rapid and cost-effective protocols that can be completed in about five hours. This technology also incorporates unique molecular indexing to enhance sensitivity and accuracy in detecting genetic variants.

Furthermore, Amoy Diagnostics offers the **ANDAS** (AmoyDx NGS Data Analysis System), which provides a secure and efficient platform for analyzing sequencing data generated from their NGS products. The ANDAS system is designed to operate within the laboratory's local network, ensuring data security and control over sensitive patient information. This comprehensive suite of technologies not only streamlines the diagnostic process but also supports oncologists in making informed treatment decisions, ultimately contributing to improved patient outcomes in cancer care.

China

Amoy Diagnostics (AmoyDx) is a visionary diagnostic company dedicated to transforming the landscape of cancer care. 'Breaking Barriers to Precision Oncology' reflects our commitment to revolutionizing cancer diagnosis and treatment.

We are driven by four fundamental values: Innovation in Care, Accessibility and Equity, Collaboration and Partnership, and Integrity and Trust. These values guide our pursuit of developing groundbreaking diagnostic tools and fostering a more equitable, collaborative, and trustworthy approach to oncology.

Join us as we pave the way to a future where precision cancer care is a reality for every patient, everywhere.

Amoy Diagnostics

Company Details